J&J Was Aware of Hip Implant Failure Rates

When a British metal implant registry revealed that Johnson & Johnson’s hip implant devices had high failure rates, Johnson & Johnson was quick to refute those allegations. However, records published in the New York Times now indicate that the company was aware at the time that the implants would fail in approximately 40% of the patients who received it.

Johnson & Johnson’s subsidiary DePuy Orthopedics is currently named in thousands of personal injury lawsuits filed by persons, who suffered hip implant failures within 5 years of being implanted with these devices. The high failure rates associated with the ASR Hip Resurfacing System and the ASR XL Acetabular System have meant severe trauma for patients implanted with these devices. When an implant fails, the person may need revision surgery to replace the device. The revision surgeries are not only painful, but also complicated, and there is no guarantee of success.

The National Joint Registry of England and Wales found that the implants were failing prematurely at a rate that was much higher than competing implants, and claimed that the devices were probably failing in approximately 1/3rd of the patients. New court records that have been disclosed as part of litigation against Johnson & Johnson, clearly show that the company was aware back in 2011 that there was a high failure rate associated with these devices. The company was aware of this even when it was defending its devices. However, the company never bothered to disclose that implants were expected to fail in 40% of the patients who received it.

As the lawsuits against Johnson & Johnson go to court, Los Angeles personal injury lawyers can expect more revelations about the degree of Johnson & Johnson’s awareness of the problems with the devices, and its concealment of these problems.